Anthony Kong
- Obstetrics and Gynecology top 2%
- Endometrial and Cervical Cancer Treatments 6
- Uterine Myomas and Treatments 6
- Otorhinolaryngology top 2%
- Head and Neck Cancer Studies 20
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment 6
- Oncology top 5%
- HER2/EGFR in Cancer Research 23
- Peptidase Inhibition and Analysis 9
-
- Monoclonal and Polyclonal Antibodies Research 17
-
- Lung Cancer Treatments and Mutations 12
- Co-authors
- Henry C KitchenerNick JohnsonTheresa A LawrieHisham MehannaAdrian L. HarrisMerel GijsenBanafshé LarijaniPeter J. Parker
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Anthony Kong
67 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 90
- Obstetrics and Gynecology 327
- Otorhinolaryngology 182
- Reproductive Medicine 280
- Oncology 825
- Radiology, Nuclear Medicine and Imaging 397
Countries citing papers authored by Anthony Kong
This map shows the geographic impact of Anthony Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Kong more than expected).
Fields of papers citing papers by Anthony Kong
This network shows the impact of papers produced by Anthony Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Kong. The network helps show where Anthony Kong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anthony Kong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 6 | |
| 9 | 2021 | 3 | |
| 10 | 2021 | 3 | |
| 11 | 2021 | 14 | |
| 12 | 2020 | 83 | |
| 13 | 2020 | 26 | |
| 14 | 2020 | 5 | |
| 15 | 2017 | 50 | |
| 16 | 2015 | 31 | |
| 17 | 2014 | 68 | |
| 18 | 2012 | 30 | |
| 19 | 2010 | 109 | |
| 20 | 2007 | 30 |
About Anthony Kong
Anthony Kong is a scholar working on Otorhinolaryngology, Oncology, Radiology, Nuclear Medicine and Imaging, Obstetrics and Gynecology and Reproductive Medicine, having authored 73 papers that have together received 1.8k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (23 papers), Head and Neck Cancer Studies (20 papers), Monoclonal and Polyclonal Antibodies Research (17 papers), Lung Cancer Treatments and Mutations (12 papers), Peptidase Inhibition and Analysis (9 papers), Endometrial and Cervical Cancer Treatments (6 papers), Ovarian cancer diagnosis and treatment (6 papers) and Uterine Myomas and Treatments (6 papers). The work is most often cited by research in Obstetrics and Gynecology (327 citations), Otorhinolaryngology (182 citations), Reproductive Medicine (280 citations), Oncology (825 citations) and Radiology, Nuclear Medicine and Imaging (397 citations). Anthony Kong has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Henry C Kitchener, Nick Johnson, Theresa A Lawrie, Hisham Mehanna, Adrian L. Harris, Merel Gijsen, Banafshé Larijani, Peter J. Parker, Polly Edmonds and Ioannis Roxanis. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Oncotarget, Cancer Research and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.